94110 ⎘
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring; Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring; Oxygen atoms in positions 2 and 3, e.g. isatin
ALLOSTERIC MODULATION OF MUSCARINIC ACETYLCHOLINE RECEPTOR EFFICACY
#2INDOLINONE COMPOUNDS AND USES THEREOF
#3METHODS AND COMPOSITIONS RELATING TO INHIBITION OF ALDEHYDE DEHYDROGENASES FOR TREATMENT OF CANCER
#4Compounds and Pharmaceutical Compositions Useful for Managing Sickle Cell Disease and Conditions Related Thereto
#5AN EFFICIENT NEW PROCESS FOR SYNTHESIS OF 2-AMINO-5-CHLORO-N-,3-DIMETHYLBENZAMIDE
#6SMALL MOLECULES AND THEIR USE AS MALT1 INHIBITORS
#73-HYDROXYOXINDOLE DERIVATIVES AS CRHR2 ANTAGONIST
#8CYCLOPROPENIUM COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE
#9Isatin derivative redoxamer for electrochemical device
#10Dual-functional compounds and methods of use
#11Process for synthesis of 2-amino-5-chloro-N-,3-dimethylbenzamide
#12INDOLINONE COMPOUNDS AND USES THEREOF
#13Isatin derivative redoxmer for electrochemical device
#14Efficient new process for synthesis of 2-amino-5-chloro-N,3-dimethylbenzamide
#15PRODUCTION METHOD OF QUINOLINECARBOXAMIDE DERIVATIVE OR PRODUCTION INTERMEDIATE THEREOF
#16Histone acetyltransferase activators and uses thereof
#17Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
#18Water-soluble isatin derivative, and manufacturing method and application thereof
#19Indoline analogs and uses thereof
#20Histone Acetyltransferase Activators and Uses Thereof
#21INDOLINONE COMPOUNDS AND USES THEREOF
#22Eis inhibitors
#23Breast cancer therapeutic agent containing 5′-hydroxy-5-nitro-indirubin-3′-oxime as active ingredient
#24Isatin copolymers having intrinsic microporosity
#25Oxindole compounds and pharmaceutical compositions thereof
#26Indoline analogs and uses thereof
#27Indoline analogs and uses thereof
#28HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF
#29Indolinone compounds and uses thereof
#30Indolinone compounds and uses thereof
#31Method for producing optically active carboxylic acid ester
#32Aurora kinase inhibitors
#33Methods and compositions for treating Ewings sarcoma family of tumors
#34Indolinone compounds and uses thereof
#35Inhibitors of beta-catenin in treatment of colorectal cancer
#36Targeting of EWS-FLI1 as anti-tumor therapy
#37Amine derivative or salt thereof
#38Isatin compounds, compositions and methods for treatment of degenerative diseases and disorders
#39Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#40Methods and compositions for treating Ewings sarcoma family of tumors
#41Chemical process for preparing spiroindolones and intermediates thereof
#42Isatin compounds, compositions and methods for treatment of degenerative diseases and disorders
#433-substituted-3-hydroxy oxindole derivatives and process for preparation thereof
#44Composition for preventing or treating obesity, dyslipidemia, fatty liver or diabetes containing indole-3-carbinol derivative as active ingredient
#45Isatin derivatives, pharmaceutical compositions thereof, and methods of use thereof
#46Small molecule inhibitors of protein kinases
#47Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#48Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
#49Synthesis of amines and intermediates for the synthesis thereof
#50Synthetic mycotoxin adsorbents and methods of making and utilizing the same
#51S1P receptors modulators
#52Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#53Small molecules for inhibition of protein kinases
#54Synthesis of amines and intermediates for the synthesis thereof
#55Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#56Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#57Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#58Synthetic mycotoxin adsorbents and methods of making and utilizing the same
#59Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
#60INDOLINONE COMPOUND
#61BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS
#62OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS)
#63Targeting of EWS-FLI1 as anti-tumor therapy
#64Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#65Synthesis of amines and intermediates for the synthesis thereof
#66Targeting of EWS-FLI1 as anti-tumor therapy
#67Compounds
#68Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
#69Oxindole derivative as feeding control agent
#70Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#71Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#721,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle
#73Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#74Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#752-phenyl-3,3,3-trifluoro-2-hydroxy-propionic acid derivatives
#76Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#77Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#78Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#79Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#80Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#81Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#82SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF
#83BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS
#84N-Acylated lipophilic amino acid derivatives
#85BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS
#86Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them
#87New compounds
#88Oxindole compounds and their uses as therapeutic agents
#89Aniline derivatives
#902-phenyl-3,3,3-trifluoro-2-hydroxy-propionic acid derivatives
#91Benzimidazolone and dihydroindolone derivatives and uses thereof
#92Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereof
#93Benzimidazolidinone derivatives as muscarinic agents
#94Process for preparing isatins with control of side-product formation
#95Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#96Derivatization of non-natural amino acids and polypeptides
#97Therapies using non-natural amino acids and polypeptides
#98Benzimidazolidinone derivatives as muscarinic agents
#99Benzimidazolidinone derivatives as muscarinic agents
#100Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#101Amide derivatives
#102Oral general anesthetics and metabolitically resistant anticonvulsants
#103Synthesis of amines and intermediates for the synthesis thereof
#104Benzimidazolidinone derivatives as muscarinic agents
#105N-acylated lipophilic amino acid derivatives
#106Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPs)